Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of a new drug on nerve sensitivity in healthy volunteers
NL-OMON60819Phase 1Completed
- Sponsor
- QurAlis
- Start
- Sep 2024
- Countries
- 1
01
Overview
Phase 1 trial in Peripheral nerve hyperexcitability (PNH), sponsored by QurAlis. Started Sep 2024; status: completed.
02
Conditions
Peripheral nerve hyperexcitability (PNH)
Beyond the preview
Go deeper on NL-OMON60819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60819.